空腹血糖受损3年进展为糖尿病的蛋白质组学特征:ARIC研究
在ARIC研究中,对3786名空腹血糖受损(IFG)参与者进行约3年随访,发现6种血浆蛋白与糖尿病进展相关,涉及碳水化合物代谢和糖酵解通路;将这些蛋白加入预测模型可改善区分度和风险重分类,部分蛋白在MESA队列中得到验证。
要点
- 6种蛋白与IFG 3年进展为糖尿病相关,包括PTPRS、ANTXR2、ADIPOQ、CNTFR、TMEM132C和ADAMTSL2。
- 加入6种蛋白可改善预测模型区分度(ΔAUC 0.03,P=0.005)和净重分类(训练集12.2%,验证集12.0%)。
- 碳水化合物代谢和糖酵解是相关关键通路,2种蛋白在MESA队列中验证。
核心结论
- 发现与IFG 3年进展为糖尿病相关的蛋白质,并改善糖尿病风险分层。
研究设计与样本
- 在ARIC研究visit 2(1990-1992)至visit 3(1993-1995)期间,检测4955种血浆蛋白(SomaScan v4.0)与IFG进展的关联,使用逻辑回归模型校正人口学、心血管代谢危险因素和基线血糖,Bonferroni校正P<10^-5。
- 样本为3786名IFG参与者,平均年龄57(SD 6)岁,52%女性,28%黑人。
- 在MESA队列中验证结果。
主要发现
- 3年糖尿病累积发病率为6%。
- 6种蛋白与约3年进展为糖尿病相关:PTPRS、ANTXR2、ADIPOQ、CNTFR、TMEM132C降低,ADAMTSL2升高。
- 碳水化合物代谢和糖酵解是富集的关键通路。
- 加入6种蛋白后模型乐观校正AUC为0.81,ΔAUC 0.03(P=0.005),净重分类训练集12.2%、内部验证集12.0%,预测风险五分位跨度从<1%到约20%。
- 6种蛋白中有2种在MESA中得到验证(P<0.008)。
关键数值与推荐
- IFG定义为空腹血糖100-125 mg/dL且无糖尿病;糖尿病定义为诊断、用药或空腹血糖≥126 mg/dL。
- Bonferroni校正P<10^-5;MESA验证P<0.008。
- 风险重分类使用3年风险阈值6%和15%。
临床怎么用
- 基于6种蛋白的蛋白质组学特征可辅助IFG患者3年糖尿病风险分层。
- 相关通路(碳水化合物代谢和糖酵解)可能提供干预靶点线索。
局限性
- 6种蛋白中仅2种在MESA队列中得到验证。
- 研究结果基于ARIC和MESA队列,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify proteomic signatures underlying 3-year progression from impaired fasting glucose (IFG) to diabetes. RESEARCH DESIGN AND METHODS: We examined IFG progression in the Atherosclerosis Risk in Communities (ARIC) study from visit 2 (1990-1992) to visit 3 (1993-1995). We tested associations of 4,955 plasma proteins (SomaScan version 4.0) with ∼3-year progression from IFG (FG 100-125 mg/dL without diabetes) to diabetes (diagnosis, medication, or FG ≥126 mg/dL) using logistic regression models adjusted for demographics, cardiometabolic risk factors, and baseline glucose with Bonferroni correction (P < 10-5). We explored biological pathways enriched among the top proteins and calculated improvements in prediction (ΔAUC and net reclassification using 3-year risk thresholds of 6% and 15% in 80% training and 20% internal validation subsamples). We validated results in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort. RESULTS: There were 3,786 ARIC participants with IFG (mean [SD] age 57 [6] years, 52% female, 28% Black individuals). The 3-year cumulative incidence of diabetes was 6%. Six proteins were associated with ∼3-year progression to diabetes, namely lower receptor-type tyrosine-protein phosphatase S (PTPRS), anthrax toxin receptor 2 (ANTXR2), adiponectin (ADIPOQ), ciliary neurotrophic factor receptor subunit α (CNTFR), transmembrane protein 132C (TMEM132C), and higher ADAMTS-like protein 2 (ADAMTSL2). Altered carbohydrate metabolism and glycolysis were key pathways. Adding the six proteins to covariates improved discrimination (optimism-corrected AUC 0.81, ΔAUC 0.03, P = 0.005) and net reclassification (training 12.2%, internal validation 12.0%) with predicted diabetes risk quintiles spanning <1% to ∼20%. Two of the six proteins were validated in MESA (P < 0.008). CONCLUSIONS: We identified proteins associated with 3-year IFG progression, with improvements in diabetes risk stratification.
引用
- Rooney MR, Echouffo Tcheugui JB, Chen J, et al. Proteomic Signatures of 3-Year Progression From Impaired Fasting Glucose to Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2026. PMID: 42347027. doi:10.2337/dc26-0498
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。